glp 1 medications mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review GLP-1 Receptor Agonists as Treatments

Hyperglycemic crises and related neurological sequelae including seizures and altered consciousness may link to suboptimal glycemic control during GLP-1 RA therapy

Despite having a lower degree of polymerization (DP up to 25), they undergo microbial fermentation, supporting gut balance and SCFA production

K.AsmarA.MadsbadS.HolstJ

Nakamura, K., et al

Their visual (on the right, click for a larger view) leaves us intrigued about results to come from further research

All these pathways eventually lead to an increase in the intracellular Ca 2+ concentration, thereby promoting the mitochondrial synthesis of ATP, and the release of insulin particles into the blood through exocytosis